| |
Metastatic disease
|
Relapse-free disease
|
p-value
|
|---|
| |
n = 15
|
n = 23
| |
|---|
|
miRNA-155
|
6.07*
|
15.58
|
0.095
|
| |
1.80-21.03**
|
7.29-27.58
| |
|
miRNA-141
|
0.072
|
0.102
|
0.682
|
| |
0.033-0.671
|
0.046-0.181
| |
|
miRNA-210
|
36.758
|
41.137
|
0.317
|
| |
12.147-62.417
|
28.581-82.332
| |
|
miRNA-200c
|
0.266
|
0.301
|
0.502
|
| |
0.108-0.487
|
0.185-0.517
| |
|
miRNA-106a
|
14.522
|
25.126
|
0.081
|
| |
12.469-24.862
|
16.923-42.519
| |
|
miRNA-106b
|
10.387
|
16.451
|
0.030
|
| |
6.591-15.950
|
11.119-25.831
| |
|
miRNA-200b
|
6.556
|
7.804
|
0.87
|
| |
3.849-14.096
|
3.697-14.676
| |
|
miRNA-182
|
0.302
|
0.081
|
0.194
|
| |
0.051-0.728
|
0.036-0.321
| |
- * Medians of expression level related to RNU6B with **25th and 75th percentiles.
